{
  "url": "https://openlegislation.uk/cosmetic-products-regulation-ec-no-12232009-restriction-of-chemical-substances-amendment-and-transitional-provisions-regulations-2026/schedule",
  "json_url": "https://openlegislation.uk/cosmetic-products-regulation-ec-no-12232009-restriction-of-chemical-substances-amendment-and-transitional-provisions-regulations-2026/schedule.json",
  "legislation": "uksi/2026/23",
  "legislation_title": "The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026",
  "legislation_url": "https://openlegislation.uk/cosmetic-products-regulation-ec-no-12232009-restriction-of-chemical-substances-amendment-and-transitional-provisions-regulations-2026",
  "path": "schedule",
  "kind": "schedule",
  "number": null,
  "heading": "Entries to be inserted into Annex 2",
  "text": "“\n1745\nDiphenyl(2,4,6-trimethylbenzoyl)phosphine oxide\n75980-60-8\n278-355-8\n1746\nclothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine\n210880-92-5\n433-460-1\n1747\nDimethyl propylphosphonate\n18755-43-6\n242-555-3\n1748\nDibutyltin maleate\n78-04-6\n201-077-5\n1749\nDibutyltin oxide\n818-08-6\n212-449-1\n1750\n2,2’, 6,6’-tetrabromo-4,4’-isopropylidenediphenol; tetrabromobisphenol-A\n79-94-7\n201-236-9\n1751\n1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs.\n68953-84-4\n273-227-8\n1752\n4-Methylimidazole\n822-36-6\n212-497-3\n1753\nAcetone Oxime\n127-06-0\n204-820-1\n1754\nBenthiavalicarb isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate\n177406-68-7\n1755\n2,3-epoxypropyl neodecanoate\n26761-45-5\n247-979-2\n1756\nMulti-walled carbon tubes (synthetic graphite in tubular shape) with a geometric tube diameter range ≥ 30 nm to < 3 µm and a length ≥ 5 µm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T\n1757\n7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptan-3-carboxylate\n2386-87-0\n219-207-4\n1758\n2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4- (morpholin-4-yl)phenyl]butan-1-one\n119344-86-4\n438-340-0\n1759\nS-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (R a S a)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methox-ypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide]\n87392-12-9\n1760\nTrimethyl borate\n121-43-7\n204-468-9\n”",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2026/23/schedule",
    "retrieved_at": "2026-10-28T21:07:31.944045+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}